Mechanistic research
Laboratory studies can explore biological pathways. They do not by themselves establish a benefit in people.
RESEARCH & CONTEXT
Read beyond
the headline.
Evaluate what each study tested, what it found and what it cannot establish.
Separate three levels of evidence
Human research
Read the preparation, population, comparison, primary outcome and limitations together.
Product-specific evidence
Confirm that the tested ingredient, chemical form, composition and intended use match the product being evaluated.
SELECTED PUBLISHED STUDY
A 12-month randomized trial
A 2022 study of a spermidine-rich wheat-germ supplement did not show a significant benefit on the primary memory outcome compared with placebo. It evaluated a different preparation, not Dr.SPD.
Study design, findings & limitationsDr.SPD research and intellectual property
A supplied CNIPA notice identifies Chinese patent application 202610184964.9, relating to a spermidine trihydrochloride single crystal and its preparation method. It names Shanghai EGT Synbio Group Co., Ltd. as applicant and records passage of preliminary examination on 24 March 2026.
This describes the supplied notice at its issue date. A grant certificate and a current legal-status check are not included here. The filing does not establish clinical efficacy or freedom to operate.
No Dr.SPD human clinical trial report was supplied in the document set reviewed on 28 October 2026. Published studies of other preparations remain separate from evidence for this ingredient.
Ask for product-specific evidenceSTART A TECHNICAL CONVERSATION
Your formulation.
Your next question.
Share your target market, application and ingredient requirements. Ask for the current documents, sample availability or commercial terms.